HighCycle Study: Acetazolamide, High Altitude and Plasma Volume — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

HighCycle Study: Acetazolamide, High Altitude and Plasma Volume — Stella

Recruiting

Back to High Altitude Effects trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Kyrgyzstan

National Center for Cardiology and Internal Medicine, Bishkek

Key details

Phase

Post-approval study

Sponsor

Centre d'Expertise sur l'Altitude EXALT

Collaborators

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov, University of Zurich

Enrollment target

~270 participants

Started

July 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 44 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov